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ABSTRACT 
Small non-coding RNAs, including microRNAs (miRNAs) and piwi-interacting RNAs (piRNAs), 
play an important role in gene expression regulation and are involved in many biological and 
pathological processes. Study of small RNA expression and function in cancer cells could 
contribute to greater understanding of how small RNAs are involved in cancer development. The 
main goal of this thesis work was to investigate the expression and functions of these small RNAs 
in adrenocortical carcinoma (ACC) and testicular germ cell tumors (TGCTs).  
 
In Paper I, we identified a set of miRNAs that could distinguish ACC from its normal and benign 
counterparts. miR-483-3p, miR-483-5p, miR-21 and miR-210 expressions were higher, while miR-
195 and miR-497 were lower in ACC. Suppression of miR-483-3p and over-expression of miR-195 
or miR-497 reduces cell proliferation and increases apoptosis in ACC cells. The protein expression 
of PUMA, a target of miR-483-3p, is down-regulated in ACC and inversely correlated with the 
increased expression of miR-483-3p. Additionally, increased expressions of miR-503, miR-1202, 
and miR-1275 are associated with short overall survival of ACC patients.  
 
In Paper II, we evaluated the expression levels of core components of miRNA biogenesis in ACC. 
We observed significant increased expressions of TARBP2, DICER and DROSHA in ACC as 
compared to benign tumors or adrenal cortices. Higher TARBP2 mRNA is a strong predictor for the 
discrimination of ACC from the non-carcinoma cases. Suppression of TARBP2 decreases cell 
proliferation and increases apoptosis in ACC cells. We also demonstrate that copy number gain of 
TARBP2 gene and its regulation by miR-195 and miR-497 could contribute to TARBP2 
overexpression in ACC.     
 
In Paper III, we identified a set of deregulated miRNAs (including reduced expression of miR-
506~514 cluster and increased expressions of miR-21 and miR-223) in TGCT. Overexpression of 
miR-514a-3p, a member of miR-506~514 cluster, inhibits cell proliferation and induces apoptosis in 
TGCT cell lines. The apoptotic effect of miR-514a-3p is mediated through direct regulation of 
PEG3. Silencing of PEG3 or overexpression of miR-514a-3p leads to reduced nuclear accumulation 
of p50 and NF-κB reporter activity, suggesting that miR-514a-3p and PEG3 play a role in NF-κB 
pathway. Importantly, high expression of PEG3 and nuclear p50 were found in a large proportion of 
TGCT samples.  
 
In Paper IV, we show that global piRNA expression is down-regulated in both human and mouse 
TGCTs compared to normal testes. Using high-throughput sequencing approaches, we demonstrate 
that most piRNA precursor transcripts were present and transcriptionally active in TGCTs. Our 
RNA sequencing data indicate that the piRNA biogenesis factors MOV10L1, DDX4, MAEL, 
PIWIL3, and TDRD6 were significantly down-regulated in TGCTs, suggesting loss of piRNA 
expression in TGCT is likely due to impaired processing of piRNA precursors. 
 
Overall, this thesis work describes the biological and clinical role of small RNAs and deregulation 
of their processing factors in both human ACC and TGCTs. 
 
